UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
RBC Bearings
RBC
$18B
| $6.5M | ﹤0.01% |
27,937
-100
| -0.4% | -$23K |
|
1077
White Mountains Insurance
WTM
$5.13B
| $6.47M | ﹤0.01% |
4,699
-95
| -2% | -$136K |
|
1078
Assured Guaranty
AGO
$3.34B
| $6.46M | ﹤0.01% |
128,467
-4,232
| -3% | -$246K |
|
|
DCPH
1079
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.43M | ﹤0.01% |
416,306
+380,355
| +1,058% | +$6.35M |
|
1080
Globus Medical
GMED
$11.2B
| $6.43M | ﹤0.01% |
113,477
-7,450
| -6% | -$478K |
|
1081
Saia
SAIA
$9.72B
| $6.42M | ﹤0.01% |
23,609
-2,848
| -11% | -$760K |
|
1082
Celsius Holdings
CELH
$7.03B
| $6.35M | ﹤0.01% |
204,999
+90,528
| +79% | +$2.86M |
|
1083
Vontier
VNT
$4.74B
| $6.33M | ﹤0.01% |
231,580
+3,890
| +2% | +$94K |
|
1084
Ionis Pharmaceuticals
IONS
$9.4B
| $6.32M | ﹤0.01% |
176,733
+937
| +0.5% | +$35.2K |
|
1085
Globant
GLOB
$1.61B
| $6.32M | ﹤0.01% |
38,507
-100
| -0.3% | -$16.3K |
|
1086
EXL Service
EXLS
$5.29B
| $6.28M | ﹤0.01% |
194,060
+840
| +0.4% | +$27.8K |
|
1087
Choice Hotels
CHH
$4.8B
| $6.27M | ﹤0.01% |
53,525
-1,766
| -3% | -$212K |
|
|
CNH
1088
CNH Industrial
CNH
$17.5B
| $6.27M | ﹤0.01% |
410,569
-74,100
| -15% | -$1.2M |
|
1089
SouthState Bank Corp
SSB
$10.5B
| $6.25M | ﹤0.01% |
87,714
+2,392
| +3% | +$186K |
|
1090
Wendy's
WEN
$1.46B
| $6.24M | ﹤0.01% |
286,607
-2,103
| -0.7% | -$46.2K |
|
1091
Flowserve
FLS
$10.2B
| $6.19M | ﹤0.01% |
182,132
+1,645
| +0.9% | +$55.1K |
|
1092
Bright Horizons
BFAM
$3.86B
| $6.15M | ﹤0.01% |
79,928
-1,562
| -2% | -$120K |
|
1093
Chewy
CHWY
$9.63B
| $6.12M | ﹤0.01% |
163,857
-5,139
| -3% | -$213K |
|
|
NXRT
1094
NexPoint Residential Trust
NXRT
$652M
| $6.12M | ﹤0.01% |
140,240
+17,312
| +14% | +$797K |
|
1095
Rithm Capital
RITM
$5.69B
| $6.1M | ﹤0.01% |
762,978
+12,068
| +2% | +$106K |
|
1096
iShares Core S&P Small-Cap ETF
IJR
$112B
| $6.09M | ﹤0.01% |
+62,996
| New | +$6.3M |
|
1097
Boyd Gaming
BYD
$6.06B
| $6.07M | ﹤0.01% |
94,735
+7,774
| +9% | +$481K |
|
1098
Kyndryl
KD
$3.05B
| $6.02M | ﹤0.01% |
407,708
+33,916
| +9% | +$481K |
|
1099
Alkermes
ALKS
$8.25B
| $6.02M | ﹤0.01% |
213,376
+23,851
| +13% | +$650K |
|
1100
Insmed
INSM
$28.6B
| $6.01M | ﹤0.01% |
352,758
-2,615
| -0.7% | -$50.8K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.